RH shares rose roughly 10.2% over the last 30 days, rebounding from a mid-October low near $111 to about $137 as of late October 2026. The recovery was punctuated by a 9.5% single-session surge on October 22, as investor attention shifted to the RH Estates collection, new gallery openings, and international expansion.

SPY is a broad-market, large-cap ETF tracking the S&P 500 Index with roughly 500 holdings across all 11 sectors, while XLK is a concentrated technology-sector fund holding about 75–80 stocks. Both funds are passively managed, but their risk profiles differ sharply: XLK carries a meaningfully higher beta and standard deviation than SPY.

DIA, an ETF tracking the Dow Jones Industrial Average, is down -1.11% during regular market hours, falling to $522.04 from a prior close of $527.89. The primary catalyst is a rally in oil prices to five-month highs, with Brent near $116, driven by U.S.-Israel-Iran tensions and attacks on Strait of Hormuz vessels.

SPY delivers broad, all-sector exposure to roughly 500 large-cap U.S. companies through the S&P 500 Index, while XLF concentrates entirely in the financials segment of that same index. Structurally, SPY is a unit investment trust (UIT) , a legacy structure that cannot reinvest dividends internally, whereas XLF is a more modern open-end fund that can.

SPY offers broad, diversified exposure to roughly 500 large-cap U.S. stocks across all 11 market sectors, while XLE is a concentrated, single-sector fund holding about 25 energy companies. Both funds are passive, market-capitalization-weighted ETFs (exchange-traded funds) sponsored by State Street Global Advisors, yet they serve fundamentally different portfolio roles.

SPY tracks the S&P 500 Index, providing broad diversification across roughly 500 large-cap U.S. companies, while XLRE is a concentrated, non-diversified fund holding only about 30 real estate equities. The two funds do not compete directly; SPY is a core total-market-style holding, whereas XLRE offers single-sector, thematic exposure to real estate investment trusts (REITs) and real estate services.

CURV fell -5.12% to roughly $2.04 during the regular session, extending a roughly -12% slide over the prior week. The decline follows the company's Oct. 19 announcement that CFO Paula Dempsey is resigning, with Will Langley becoming interim CFO on Oct. 28, adding leadership uncertainty.

ZJK fell -4.62% during regular market hours, trading around $1.65 versus the prior session's $1.73 close. The decline was not tied to company-specific news, reflecting continued thin-volume selling in this low-float micro-cap name.

GOAI fell -5.23% to about $1.45, down from its prior session close of $1.53. The decline occurred during regular market hours on October 23.

B&G Foods (BGS) is trading down -5.12% intraday during regular market hours, slipping from a prior close of $2.15 to roughly $2.04. The decline extends a prolonged slide, with shares down about -35% over the past three months versus a roughly flat consumer staples industry.

QNC is trading down -5.17% to $1.10 during regular NYSE American hours, versus the prior session's $1.16 close. The decline reflects ongoing dilution concerns around the proposed Plurilock acquisition, where roughly 70% of consideration is paid in QNC stock.

SHMD is trading down roughly -4.66% during regular market hours, extending a sharp multi-week decline. The slide follows the company's cut to its 2026 adjusted EBITDA margin guidance (from above 12% to 6%–9%) on a lower-margin China production shift.

LANV closed at $0.84 on Oct 22, down -4.44% (-$0.039) from the prior session's $0.879 close, with the decline occurring during regular market hours. No single company-specific catalyst emerged; the move extends a sustained downtrend in this thinly traded luxury micro-cap, which remains down roughly -50% year-to-date.

INDI is trading down -5.36% intraday to about $1.59, extending losses from Wednesday's $1.68 close during regular market hours. Primary catalyst is analyst capitulation, with TD Cowen cutting its target to $2.00 from $4.50 (Hold) and B. Riley lowering to $5 from $6, pressuring sentiment.

ABOS is trading down -4.85% to $1.96 during regular market hours, retreating from the prior session's $2.06 close. The decline reflects pre-earnings caution with no major company-specific headline, following several sessions of gains earlier in the week.

MMLP fell -5.53% during regular market hours, with the last trade at $2.045 versus the prior session's $2.17 close. The decline tracked broad weakness across midstream and energy peers as crude oil prices retreated and rising Treasury yields pressured risk assets sector-wide.

AIFU Inc. (AIFU) is trading down -5.56% during regular market hours, last at $10.70 versus the prior session close of $11.33. The decline follows ongoing dilution concerns tied to a $135 million private placement priced at a deep discount in mid-October.

Equillium (EQ) fell -4.72% during regular trading, sliding from a $1.27 prior close to about $1.21. The move extends a sharp multi-session downtrend, following a -10.56% drop on Oct 22 that broke below both the 50-day and 200-day moving averages.

PDS Biotech (PDSB) is trading down -6.03% to about $1.09 during regular market hours, extending the prior session's -6.45% decline. The move reflects profit-taking after an outsized speculative rally; shares surged +29% on Oct 21 and touched $1.79 earlier in October.

BDTX is trading down -8.65% to $1.90 during regular market hours, versus its prior close of $2.08. The decline follows mixed Phase II data for its lead silevertinib program in frontline EGFR-mutant NSCLC, weighing on investor sentiment.